From COVID-19 vaccines to rare disease treatments, RNA has become key to tackling many of biotech’s tough obstacles. Stoke ...

It's a sight to see as about 5,000 plants of the traditional holiday flower — called poinsettia in English and cuetlaxochitl ...

Rznomics, Inc. announced to secure its expanded access program (EAP) from the United States Food and Drug Administration (FDA) for RZ-001, RNA editing gene therapy product for the ...

By modulating mRNA splicing, ReviR aims to develop a potential therapeutic intervention for ... “KDA is excited to partner with ReviR Therapeutics on the potential use of its innovative gene editing ...

ReviR Therapeutics, a pioneering biotechnology company focused on developing novel small molecule RNA modulators for neurogenetic diseases, announced a groundbreaking research grant ...